Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conduction System of the Heart01:20

Conduction System of the Heart

4.4K
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
4.4K
Conduction System of the Heart01:19

Conduction System of the Heart

14.1K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
14.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

451
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
451
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

514
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
514
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

679
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
679

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jervell and Lange-Nielsen Syndrome Related Clinical Genetics and Experimental Models.

Pediatric discovery·2026
Same author

Finite element modeling of sarcoplasmic reticular intraluminal Ca<sup>2+</sup> diffusional fluxes during amphibian striated muscle excitation-contraction coupling.

Frontiers in physiology·2026
Same author

Structural implications of glycosylation on the voltage-gated sodium channel β3-subunit.

Journal of structural biology·2026
Same author

Very high-power short duration radiofrequency ablation to achieve pulmonary vein isolation: the AIR HPSD registry.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Comparing GLP-1 agonists versus other weight loss interventions on risk of atrial fibrillation recurrence after catheter ablation: a meta-analysis.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Predictors of Favorable Neurological Outcomes Following Atrioesophageal Fistula After Radiofrequency Catheter Ablation for Atrial Fibrillation: A Subanalysis of the POTTER-AF Study.

Circulation. Arrhythmia and electrophysiology·2026

Related Experiment Video

Updated: Feb 25, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

20.7K

Progressive Conduction Diseases.

Claire A Martin1, Christopher L-H Huang1, Andrew A Grace2

  • 1The Physiology Department, University of Cambridge, Downing Site, Cambridge CB2 3EG, UK.

Cardiac Electrophysiology Clinics
|August 4, 2017
PubMed
Summary
This summary is machine-generated.

Progressive cardiac conduction disease (PCCD) involves genetic factors like SCN5A mutations, leading to varied heart rhythm issues. A mouse model shows PCCD can cause cardiac remodeling and slowed conduction.

More Related Videos

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

10.9K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

Related Experiment Videos

Last Updated: Feb 25, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

20.7K
Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

10.9K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Progressive cardiac conduction disease (PCCD) is a significant cause of illness, stemming from a mix of genetic, environmental, and physiological factors.
  • Mutations in the cardiac sodium channel gene, SCN5A, are key genetic contributors to PCCD.
  • The condition presents with variable electrocardiographic patterns, from isolated conduction defects to arrhythmias and cardiomyopathy.

Purpose of the Study:

  • To investigate the mechanisms underlying Progressive Cardiac Conduction Disease (PCCD).
  • To explore the role of SCN5A gene variants in PCCD pathogenesis.
  • To understand the link between PCCD, cardiac remodeling, and altered gene expression.

Main Methods:

  • Utilized a heterozygotic Scn5a mouse model to study PCCD.
  • Analyzed electrocardiographic phenotypes and cardiac remodeling.
  • Examined the expression of genes involved in cardiac impulse propagation.

Main Results:

  • The Scn5a mouse model demonstrated slowed intracardiac conduction and cardiac remodeling consistent with clinical PCCD.
  • PCCD was associated with altered expression of genes for calcium-activated ion channels and cytoskeletal proteins.
  • These changes occurred irrespective of the presence of structural cardiac abnormalities.

Conclusions:

  • Genetic factors, particularly SCN5A mutations, play a crucial role in Progressive Cardiac Conduction Disease.
  • PCCD can induce cardiac remodeling and conduction abnormalities, as evidenced by the mouse model.
  • Altered expression of genes regulating ion channels and cytoskeletal components contributes to PCCD pathophysiology.